Surrozen Revenue and Competitors
Estimated Revenue & Valuation
- Surrozen's estimated annual revenue is currently $14.3M per year.
- Surrozen received $50.0M in venture funding in March 2019.
- Surrozen's estimated revenue per employee is $155,000
- Surrozen's total funding is $253M.
Employee Data
- Surrozen has 92 Employees.
- Surrozen grew their employee count by -25% last year.
Surrozen's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | SVP and Head Talent & Culture | Reveal Email/Phone |
3 | VP, Development Operations | Reveal Email/Phone |
4 | EVP, Research | Reveal Email/Phone |
5 | VP Corporate Development and Strategy | Reveal Email/Phone |
6 | Head Information Technology | Reveal Email/Phone |
7 | VP and Head Regulatory Affairs | Reveal Email/Phone |
8 | Director Finance | Reveal Email/Phone |
9 | Director Finance | Reveal Email/Phone |
10 | Director Finance and Controller | Reveal Email/Phone |
Surrozen Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Surrozen?
Surrozen is a biotechnology company focused on discovering and developing novel regenerative medicines with a focus on unlocking the powerful self-renewal properties of the body through specific control of the Wnt signaling pathway. Surrozen is founded by four leading edge scientists from Stanford University: K. Christopher Garcia, Ph.D.; Roel Nusse, Ph.D.; Calvin Kuo, M.D., Ph.D.; and Claudia Janda, Ph.D. Each has conducted extensive research on Wnt signaling, with findings that together shape Surrozen's technology and approach to therapeutic development. The company is backed by The Column Group, a leading biotechnology venture capital firm. We are currently seeking highly creative scientists to join our founding team, and invite you to explore career opportunities on our website. If you don't find a perfect job match, but think Surrozen may be the right place for you, please submit your resume to careers@surrozen.com.
keywords:N/A
$253M
Total Funding
92
Number of Employees
$14.3M
Revenue (est)
-25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Surrozen News
Surrozen (NASDAQ:SRZN) Stock Rating Upgraded by Zacks Investment Research. Posted by admin on Apr 22nd, 2022. Share on Twitter Share on Facebook Share on...
Surrozen (NASDAQ:SRZN) Downgraded to Sell at Zacks Investment Research. Posted by admin on Apr 13th, 2022. Share on Twitter Share on Facebook Share on...
Equities analysts expect Surrozen, Inc. (NASDAQ:SRZN Get Rating) to announce ($0.54) earnings per share for the current fiscal quarter,...
SOUTH SAN FRANCISCO, Calif., April 11, 2019 (GLOBE NEWSWIRE) -- Surrozen Inc., a company discovering and developing novel ...
Surrozen Inc., a San Francisco, CA-based biopharmaceutical company, secured $50m in Series B financing. Backers included Horizons Ventures, Hartford HealthCare Endowment, NS Investment and the Column Group. Proceeds from the financing will be used to advance the company’s antibody discovery an ...
Other Companies in South San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $16.6M | 95 | 6% | N/A |
#2 | $4M | 99 | -7% | $308.6M |
#3 | $21M | 100 | 4% | N/A |
#4 | $27.5M | 102 | 1% | N/A |
#5 | $75M | 104 | 7% | N/A |
Surrozen Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2017-02-16 | $33.0M | A | The Column Group | Article |
| 2019-03-15 | $50.0M | B | Horizons Ventures, | Article |